Atezolizumab Plus Bevacizumab With HCC and HBV Infection
Clinical trial NCT04180072 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04180072
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2025-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.